Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?

Eur Child Adolesc Psychiatry. 2016 Apr;25(4):339-40. doi: 10.1007/s00787-016-0845-2.

Authors

Pieter J Hoekstra¹, Jan K Buitelaar²

Affiliations

¹ Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. p.hoekstra@accare.nl.
² Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, and Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands.

PMID: 27021055
DOI: 10.1007/s00787-016-0845-2

No abstract available

Publication types

Editorial

MeSH terms

Adolescent
Attention
Attention Deficit Disorder with Hyperactivity / drug therapy*
Central Nervous System Stimulants / adverse effects
Central Nervous System Stimulants / therapeutic use*
Child
Evidence-Based Medicine
Humans
Methylphenidate / adverse effects
Methylphenidate / therapeutic use*

Substances

Central Nervous System Stimulants
Methylphenidate